Level II audits

The Level II audit is a diagnostic test of the Treatment Planning System performance.

Clinical Advisory Group

The Clinical Advisory Group is a panel of independent experts appointed by the CEO of ARPANSA to provide clinical and technical oversight and support to the ACDS.

Staff

The ACDS team is comprised of highly trained and experienced professionals to carry out the dosimetry audit service, research and development programs and utilise external auditors.

Ensuring accurate dose for radiotherapy

Dose accuracy is critical to safe cancer treatment. Dosimetry audits provide assurance that the radiation dose delivered to the patient aligns with the planned dose.

ACDS news and publications

Keep up to date with the ACDS news, reports, peer-reviewed publications, and videos.

Level Ib audits

The Level Ib audit offers a more accurate measurement of the Linac output than the Level I audit. ACDS staff visit the facility and perform on-site measurements using ACDS dosimetry equipment.

Level III audits

The Level III audit is an end-to-end test of the radiotherapy treatment pathway.

Level I audits

The Level I mail out audit is an independent measurement of linac output under reference conditions.

ACDS Australia and New Zealand datasets

The Australia and New Zealand datasets show the dose variation as measured by the ACDS in audits to date excluding follow up audits.

ARPANSA develops audit for new MRI-Linac

ARPANSA’s Australian Clinical Dosimetry Service (ACDS) has carried out audits on a new Elekta Unity MRI-Linac in Townsville, Queensland before the treatment of the first patient.

Access to information FOI disclosure log Information public scheme